uridine diphosphate glucuronic acid and Congenital Disorders of Glycosylation

uridine diphosphate glucuronic acid has been researched along with Congenital Disorders of Glycosylation in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Barry Iii, CE; Beeson, D; Belaya, K; Bibb, MJ; Boshoff, HI; Burgess-Brown, NA; Bushell, SR; Carpenter, EP; Chalk, R; Chu, A; Cochrane, SA; Davis, BG; Dong, YY; Hamedzadeh, S; Lee, SS; Liu, WM; Liu, WW; Lucas, R; Machida, T; Mehmood, S; Minall, L; Mukhopadhyay, SMM; Park, Y; Pike, ACW; Robinson, CV; Royer, SF; Sajid, A; Shrestha, L; Strain-Damerell, C; Wang, H; Widdick, DA; Wyszyński, FJ	1

Other Studies

1 other study(ies) available for uridine diphosphate glucuronic acid and Congenital Disorders of Glycosylation

Article	Year
Structures of DPAGT1 Explain Glycosylation Disease Mechanisms and Advance TB Antibiotic Design. Cell, 2018, 11-01, Volume: 175, Issue:4 Topics: Animals; Antibiotics, Antitubercular; Binding Sites; Congenital Disorders of Glycosylation; Enzyme Inhibitors; Female; HEK293 Cells; Hep G2 Cells; Humans; Lipid Metabolism; Mice; Molecular Docking Simulation; Mutation; N-Acetylglucosaminyltransferases; Protein Binding; Sf9 Cells; Spodoptera; Tunicamycin; Uridine Diphosphate Glucuronic Acid	2018

Article

Year

Structures of DPAGT1 Explain Glycosylation Disease Mechanisms and Advance TB Antibiotic Design.

Cell, 2018, 11-01, Volume: 175, Issue:4

Topics: Animals; Antibiotics, Antitubercular; Binding Sites; Congenital Disorders of Glycosylation; Enzyme Inhibitors; Female; HEK293 Cells; Hep G2 Cells; Humans; Lipid Metabolism; Mice; Molecular Docking Simulation; Mutation; N-Acetylglucosaminyltransferases; Protein Binding; Sf9 Cells; Spodoptera; Tunicamycin; Uridine Diphosphate Glucuronic Acid

2018